Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Statistical Analysis With Missing Data

1989 • 18,117 citations

MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS

1996 • 8,991 citations

Statistical Analysis with Missing Data

2002 • 7,513 citations

Proportional hazards tests and diagnostics based on weighted residuals

1994 • 4,890 citations

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

1998 • 4,047 citations

Cancer Statistics, 2003

2003 • 3,302 citations

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

1990 • 2,226 citations

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

2003 • 2,056 citations

A multivariate technique for multiply imputing missing values using a sequence of regression models

2001 • 1,922 citations

Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer

2000 • 1,352 citations

Information and Participation Preferences Among Cancer Patients

1980 • 1,144 citations

Information Needs and Decisional Preferences in Women With Breast Cancer

1997 • 1,118 citations

Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089

2003 • 1,117 citations

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

1995 • 1,043 citations

A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients

2001 • 954 citations

Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer

2001 • 878 citations

Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

1994 • 807 citations

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

1989 • 694 citations

Predictive value of statistical models

1990 • 590 citations

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

2000 • 556 citations

Comparative Efficacy of Adjuvant Chemotherapy in Patients With Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04)

1999 • 534 citations

TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS

1996 • 488 citations

A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer

1985 • 467 citations

Cancer Patients: Their Desire for Information and Participation in Treatment Decisions

1989 • 448 citations

Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer

1999 • 431 citations

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

1998 • 416 citations

Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers

1999 • 375 citations

Cancer patients' perceptions of their disease and its treatment

1988 • 310 citations

Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study

2003 • 282 citations

Information and decision-making preferences of men with prostate cancer.

1995 • 270 citations

Adjuvant Chemotherapy Use for Medicare Beneficiaries With Stage II Colon Cancer

2002 • 242 citations

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1994 • 242 citations

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.

1998 • 241 citations

Doctor-patient communication about breast cancer adjuvant therapy.

1989 • 228 citations

Prognostic indicators of colon tumors. The gastrointestinal tumor study group experience

1986 • 222 citations

Carcinoma of the colon and rectum:The natural history reviewed in 1704 patients

1982 • 193 citations

The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer

1984 • 179 citations

The Prognostic Significance of Tumor Location and Bowel Obstruction in Dukes B and C Colorectal Cancer

1983 • 176 citations

Prognosis of node-positive colon cancer

1991 • 172 citations

DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma

1991 • 158 citations

Effectiveness of Adjuvant Fluorouracil in Clinical Practice: A Population-Based Cohort Study of Elderly Patients With Stage III Colon Cancer

2002 • 157 citations

Adjuvant therapy of colon cancer

1999 • 141 citations

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

2001 • 105 citations

Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer

2001 • 100 citations

Discussing Adjuvant Cancer Therapy

2001 • 87 citations

Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?

1994 • 48 citations

Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.

1994 • 48 citations

Adjuvant therapy for colon cancer

1997 • 43 citations

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

2001 • 21 citations

Determination of Potential Adjuvant Systemic Therapy Benefits for Patients With Resected Cutaneous Melanomas

2002 • 11 citations

Communicating the Value of Adjuvant Chemotherapy

2003 • 7 citations

Determination of Potential Adjuvant Systemic Therapy Benefits for Patients With Resected Cutaneous Melanomas

2002 • 5 citations